ask="1.20"
ask_size="1000"
average_daily_volume="553175"
bid="1.16"
bid_size="1500"
book_value="1.98"
change="-0.02"
change_from_200_day_moving_average="-2.68"
change_from_50_day_moving_average="-1.32"
change_from_52_week_high="-6.98"
change_From_52_week_low="0.09"
change_in_percent="-1.68%"
close="1.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.08"
ex_dividend_date="N/A"
float_shares="10213000"
high="1.22"
high_52_weeks="8.15"
last_trade_date="3/2/2017"
last_trade_price="1.17"
last_trade_size="949"
last_trade_time="4:00pm"
low="1.15"
low_52_weeks="1.08"
market_capitalization="21.82M"
moving_average_200_day="3.85"
moving_average_50_day="2.49"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.90"
open="1.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-69.57%"
percent_change_from_50_day_moving_average="-53.07%"
percent_change_from_52_week_high="-85.64%"
percent_change_from_52_week_low="+8.33%"
previous_close="1.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.60"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.26"
stock_exchange="NGM"
symbol="CATB"
volume="362711"
weeks_range_52="1.08 - 8.15"
